miR-21在非酒精性脂肪性肝病中的新作用 - Suppr

Suppr

超能文献

Emerging role of miR-21 in non-alcoholic fatty liver disease.

作者信息

Benhamouche-Trouillet Samira, Postic Catherine

机构信息

BordeAux Research in Translational Oncology, Univ. Bordeaux, INSERM, U1053, Bordeaux, France.

Inserm, U1016, Institut Cochin, Paris, France.

出版信息

Gut. 2016 Nov;65(11):1781-1783. doi: 10.1136/gutjnl-2015-310044. Epub 2016 Jul 19.

DOI:10.1136/gutjnl-2015-310044

PMID:27436271

Abstract

摘要

相似文献

Emerging role of miR-21 in non-alcoholic fatty liver disease.miR-21在非酒精性脂肪性肝病中的新作用

Gut. 2016 Nov;65(11):1781-1783. doi: 10.1136/gutjnl-2015-310044. Epub 2016 Jul 19.

Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.非酒精性脂肪性肝炎中微小RNA-451的下调通过AMPK/AKT途径抑制脂肪酸诱导的促炎细胞因子产生。

Int J Biochem Cell Biol. 2015 Jul;64:265-76. doi: 10.1016/j.biocel.2015.04.016. Epub 2015 May 7.

MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.微小RNA-146a-5p通过直接靶向Wnt1和Wnt5a抑制非酒精性纤维化脂肪性肝炎中肝星状细胞的激活和增殖。

Sci Rep. 2015 Nov 5;5:16163. doi: 10.1038/srep16163.

Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.无肝细胞癌患者循环miR-122与非酒精性脂肪性肝病组织病理学特征的相关性分析

BMC Gastroenterol. 2016 Dec 12;16(1):141. doi: 10.1186/s12876-016-0557-6.

miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease.miR-26a 可能有助于调节非酒精性脂肪性肝病体外人 HepG2 细胞模型中的脂肪酸和固醇代谢。

Oxid Med Cell Longev. 2018 Sep 30;2018:8515343. doi: 10.1155/2018/8515343. eCollection 2018.

A micro-RNA expression signature for human NAFLD progression.一种用于人类非酒精性脂肪性肝病进展的微小RNA表达特征。

J Gastroenterol. 2016 Oct;51(10):1022-30. doi: 10.1007/s00535-016-1178-0. Epub 2016 Feb 13.

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.肝脏中失调的微小RNA是非酒精性脂肪性肝病与冠状动脉疾病之间关联的基础。

Liver Int. 2016 Aug;36(8):1221-9. doi: 10.1111/liv.13097. Epub 2016 Mar 23.

MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.微小RNA-146b减轻高脂饮食诱导的小鼠非酒精性脂肪性肝炎。

J Gastroenterol Hepatol. 2015 May;30(5):933-43. doi: 10.1111/jgh.12878.

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.非酒精性脂肪性肝病中肌肉减少症与脂肪性肝炎及晚期肝纤维化的关系：一项荟萃分析

BMC Gastroenterol. 2018 Apr 19;18(1):51. doi: 10.1186/s12876-018-0776-0.

Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.非酒精性脂肪性肝炎发病机制：亚致死性肝细胞损伤作为肝脏炎症的驱动因素。

Gut. 2018 May;67(5):963-972. doi: 10.1136/gutjnl-2017-315691. Epub 2018 Jan 24.

引用本文的文献

Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease.外泌体在非酒精性脂肪性肝病诊断和治疗中的前景

Front Med (Lausanne). 2024 Jul 31;11:1420281. doi: 10.3389/fmed.2024.1420281. eCollection 2024.

Maternal Weight Management to Prevent the Developmental Programming of MAFLD in Offspring of Obese Mothers.肥胖母亲体重管理以预防其后代代谢相关脂肪性肝病的发育源性程序化。

Nutrients. 2023 Apr 30;15(9):2155. doi: 10.3390/nu15092155.

Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体-γ 作为非酒精性脂肪性肝病中表观遗传机制的靶点和调节剂。

Cells. 2023 Apr 21;12(8):1205. doi: 10.3390/cells12081205.

Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.非酒精性脂肪性肝病（NAFLD）：发病机制与非侵入性诊断

Biomedicines. 2021 Dec 22;10(1):15. doi: 10.3390/biomedicines10010015.

Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients.FIB4与miRNA181a联合评分预测非酒精性脂肪性肝病患者显著肝纤维化的能力。

Biomedicines. 2021 Nov 24;9(12):1751. doi: 10.3390/biomedicines9121751.

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.微小 RNA 在非酒精性脂肪性肝病发病机制中的作用。

Int J Biol Sci. 2021 Apr 29;17(7):1851-1863. doi: 10.7150/ijbs.59588. eCollection 2021.

Mechanisms and disease consequences of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的机制及疾病后果

Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.

Dysregulation of miR-192-5p in acute pancreatitis patients with nonalcoholic fatty liver and its functional role in acute pancreatitis progression.急性胰腺炎合并非酒精性脂肪肝患者 miR-192-5p 的失调及其在急性胰腺炎进展中的功能作用。

Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20194345.

MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line.miR-30b-5p 通过靶向 PPARGC1A 调控 Huh-7 细胞系的脂质代谢。

Lipids Health Dis. 2020 Apr 16;19(1):76. doi: 10.1186/s12944-020-01261-3.

Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases.微小RNA-21在肝脏疾病发病机制中的关键作用

Front Med (Lausanne). 2020 Jan 31;7:7. doi: 10.3389/fmed.2020.00007. eCollection 2020.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验